Clinical Investigation (Beta) of a New Developed Prosthetic Knee

NCT ID: NCT06748729

Last Updated: 2025-09-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-26

Study Completion Date

2024-03-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this investigation is to evaluate the efficacy of the investigational device regarding performance improvements and satisfaction in descending activities for moderate to high active prosthesis users within the intended population for the investigational device. Additionally, the overall satisfaction for activities of daily living will be evaluated after a certain time of use (4 weeks home use).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This investigation is a non-randomized single group repeated measures open label prospective design with observational and self-report measures.

Two scheduled study events are planned for amputee subjects, with 4 weeks between visits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

The test will be a non-randomized single group repeated measures open label prospective design with observational and self-report measures.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exploratory testing of a new prosthetic knee

The investigational device is provided to subjects, who then use it as their main prosthesis for a period of 4 weeks prior to returning for data collection on the device.

Group Type EXPERIMENTAL

Navii Knee

Intervention Type DEVICE

Microprocessor controlled prosthetic knee (MPK)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Navii Knee

Microprocessor controlled prosthetic knee (MPK)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 45Kg\< body weight \< 136Kg
* Cognitive ability to understand all instructions and questionnaires in the study;
* Unilateral TF/KD amputees that are regular prosthesis users for at least 3 months
* Current MPK users (passive MPKs only) regularly performing descent activities (stairs/ramps)
* Age ≥ 18 years
* Willing and able to participate in the study and follow the protocol

Exclusion Criteria

* Users with stump pain
* Users with socket problems
* Pregnant Users
* Users using Power Knee, Kenevo or mechanical knees as their prescribed prosthesis
* Alignment that cannot be matched with the Navii setup, as described in Instructions for use.
* Osseointegration
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Össur Iceland ehf

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kurt N. Gruben

Role: PRINCIPAL_INVESTIGATOR

Össur Americas

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Össur Orlando

Orlando, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIP2023120529

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anatomic Congruent Prosthetic Knee Design
NCT03633201 ACTIVE_NOT_RECRUITING NA
Personalizing MPK Prescription
NCT06399471 COMPLETED NA
DeNovo NT Ankle LDC Study
NCT01347892 UNKNOWN
StepRite Evaluation
NCT02270684 TERMINATED NA